Ledipasvir

Results: 27



#Item
11NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni)

NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni)

Add to Reading List

Source URL: www.janusinfo.se

Language: Swedish - Date: 2014-12-22 02:37:28
    12Drug Interactions Between Direct-Acting antiHCV Antivirals Sofosbuvir and Ledipasvir and HIV Antiretrovirals Reported by Jules Levin 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 19

    Drug Interactions Between Direct-Acting antiHCV Antivirals Sofosbuvir and Ledipasvir and HIV Antiretrovirals Reported by Jules Levin 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 19

    Add to Reading List

    Source URL: www.hepatitis-c-initiative.eu

      13Support Path Sample Forms Packet—Summary of Benefits Investigation Form Help patients start HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets or SOVALDI® (sofosbuvir) Patient: Sarah Adams, DOB: Patient

      Support Path Sample Forms Packet—Summary of Benefits Investigation Form Help patients start HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets or SOVALDI® (sofosbuvir) Patient: Sarah Adams, DOB: Patient

      Add to Reading List

      Source URL: www.mysupportpath.com

      Language: English - Date: 2015-02-08 21:20:00
        14Support Path Sample Forms Packet—Appeals Checklist Help patients start HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets or SOVALDI® (sofosbuvir) Here is a checklist of the forms and documents you may need for an

        Support Path Sample Forms Packet—Appeals Checklist Help patients start HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets or SOVALDI® (sofosbuvir) Here is a checklist of the forms and documents you may need for an

        Add to Reading List

        Source URL: www.mysupportpath.com

        Language: English - Date: 2015-02-08 15:20:08
        15Neue Arzneimittel Information der Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) Harvoni® (Ledipasvir/Sofosbuvir)  1

        Neue Arzneimittel Information der Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) Harvoni® (Ledipasvir/Sofosbuvir)  1

        Add to Reading List

        Source URL: www.akdae.de

        Language: German - Date: 2015-04-21 18:15:04
          16ledipasvir/sofosbuvir, 90mg/400mg, film-coated tablet (Harvoni®) SMC No[removed]Gilead Sciences Ltd 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advis

          ledipasvir/sofosbuvir, 90mg/400mg, film-coated tablet (Harvoni®) SMC No[removed]Gilead Sciences Ltd 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advis

          Add to Reading List

          Source URL: www.scottishmedicines.org.uk

          Language: English
          17Patient Information HARVONI® (har-VOE-nee) (ledipasvir and sofosbuvir) tablets Read this Patient Information before you start taking HARVONI and each time you get a refill. There may be new information. This information

          Patient Information HARVONI® (har-VOE-nee) (ledipasvir and sofosbuvir) tablets Read this Patient Information before you start taking HARVONI and each time you get a refill. There may be new information. This information

          Add to Reading List

          Source URL: www.gilead.com

          Language: English - Date: 2014-10-10 12:02:35
          18Ledipasvir Sofosbuvir Combination Cuts Cirrhotic Hepatitis C Neil Osterweil November 13, 2014 BOSTON — Nearly all patients with cirrhotic chronic hepatitis C infection who failed previous proteaseinhibitor-based therap

          Ledipasvir Sofosbuvir Combination Cuts Cirrhotic Hepatitis C Neil Osterweil November 13, 2014 BOSTON — Nearly all patients with cirrhotic chronic hepatitis C infection who failed previous proteaseinhibitor-based therap

          Add to Reading List

          Source URL: www.hepcassoc.org

          Language: English - Date: 2014-12-22 14:34:39
          19(Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C is FDA Approved -- Harvoni Achieved Cure Rates (SVR12) of[removed]Percent in Three Phase 3 Studies ---

          (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C is FDA Approved -- Harvoni Achieved Cure Rates (SVR12) of[removed]Percent in Three Phase 3 Studies ---

          Add to Reading List

          Source URL: www.hepcassoc.org

          Language: English - Date: 2014-10-14 10:50:26
          20United Health Care - F3/F4 - AASLD/IDSA Guidance Effective Date[removed][removed]Prior Authorization/Medical Necessity......Harvoni™ (ledipasvir/sofosbuvir) Based on current evidenced-based guidance from professional s

          United Health Care - F3/F4 - AASLD/IDSA Guidance Effective Date[removed][removed]Prior Authorization/Medical Necessity......Harvoni™ (ledipasvir/sofosbuvir) Based on current evidenced-based guidance from professional s

          Add to Reading List

          Source URL: www.hepcassoc.org

          Language: English - Date: 2014-11-04 08:30:33